HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

537.703

-21.461-3.84%

Number of Gainers:2

Number of Losers:29

Number of Flat:3

PE:- -

High:561.988

Open:559.271

Low:536.314

Close:559.164

Volume:82.78M

Turnover:1.54B

Market Cap:335.79B

Float Cap:300.29B

Loading ...

Zai Lab Reports 15% Revenue Growth to $460.2 Million for 2025, Highlights Major Pipeline Progress

Suzhou Basecare Medical Gets Device Registration Certificate for Fertility-Related Product

MT Newswires Live

Yixintang to Capitalize on Market Opportunities and Expand Business Boundaries for Healthcare-Consumer Integration

Zai Lab posts Q4 product revenue of USD 127.1 million, up 17%

Zai Lab Ltd - Total Revenues $127.6 Mln in Q4 2025

THOMSON REUTERS

Zai Lab Ltd: Q4 Net Loss per Share $0.05

THOMSON REUTERS

BASECARE-B's Embryo Culture Medium Receives Chinese Regulatory Approval

Jacobio Pharmaceuticals schedules board meeting to approve annual results

CANSINOBIO (06185) Issues 2025 Performance Report, Returns to Profitability

Zai Lab Reports Positive Phase 3 ADAPT OCULUS Results for VYVGART in Ocular Myasthenia Gravis

Hong Kong Stock Connect Biotech Sector Declines, ETF 520880 Drops Over 1% Amid Wide Premium

Immunotech Biopharm Invests 50 Million Yuan in Structured Deposit Product

MT Newswires Live

Zhongtai Securities: Maintaining Focus on Healthcare's Structural Opportunities and Medical AI+

BRIEF-Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN

IMMUNOTECH-B Allocates 50 Million Yuan to Structured Deposit from Shanghai Pudong Development Bank

Immunotech Biopharm - Subscribed to Structured Deposit Product With Investment Value of RMB50 Mln

THOMSON REUTERS

Revised title

AH Share Premium Rankings as of February 25

Antengene-B Shares Surge Over 6% Following Clinical Collaboration Agreement with Junshi Bio

CStone Pharmaceuticals-B Sees Further Gains Exceeding 6%, Surpassing 25% Monthly Increase

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1574/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":537.70294,"timestamp":1772093287319,"preClose":559.164,"halted":0,"volume":82783931,"delay":0,"changeRate":-0.038381,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-21.46106,"latestTime":"02-26 16:00:00","open":559.2709,"high":561.9883,"low":536.31445,"amount":1535480407,"amplitude":0.045915,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772155800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1772069400000,1772078400000],[1772082000000,1772092800000]],"pbRate":4.887113,"peRate":-39.423913,"turnoverRate":0.003099,"increases":2,"decrements":29,"flats":1,"marketCap":335788691936,"floatMarketCap":300293157216},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":561.9883,"amplitude":0.045915,"preClose":559.164,"low":536.31445,"pbRate":"4.887113","latestPrice":537.70294,"volume":82783931,"delay":0,"open":559.2709,"prevYearClose":556.26263,"prevWeekClose":571.129,"prevMonthClose":555.241,"prevQuarterClose":556.263,"fiveDayClose":557.208,"twentyDayClose":567.109,"sixtyDayClose":618.943,"secType":"PLATE","market":"HK","turnoverRate":0.003099,"peRate":-39.423913,"marketCap":335788691936,"floatMarketCap":300293157216,"timestamp":1772093287319,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":2,"down":29,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1109417244","title":"Zai Lab Reports 15% Revenue Growth to $460.2 Million for 2025, Highlights Major Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=1109417244","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109417244?lang=en_us&edition=fundamental","pubTime":"2026-02-26 21:09","pubTimestamp":1772111342,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) announced its financial results for the fourth quarter and full year 2025. Total revenue for Q4 2025 reached $127.6 million, representing a 17% increase year-over-year. Full-year 2025...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK1588","ZLAB","BK1161","BK4585","LU2488822045.USD","09688","BK4548","BK4531","BK1574","BK4588","BK4526"],"gpt_icon":0},{"id":"2614604186","title":"Suzhou Basecare Medical Gets Device Registration Certificate for Fertility-Related Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2614604186","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614604186?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:39","pubTimestamp":1772109567,"startTime":"0","endTime":"0","summary":"Suzhou Basecare Medical  obtained the Class III medical device registration certificate for its Geri Medium from China's National Medical Products Administration, according to a Thursday Hong Kong bourse filing.The core technology of the product revolves around developing a systematic solution for fertility challenges in older patients.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","BK1597","BK1222","02170"],"gpt_icon":0},{"id":"1136258056","title":"Yixintang to Capitalize on Market Opportunities and Expand Business Boundaries for Healthcare-Consumer Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=1136258056","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136258056?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:04","pubTimestamp":1772107449,"startTime":"0","endTime":"0","summary":"On February 26, Yixintang Pharmaceutical Group Co., Ltd. responded to investor inquiries via an interactive platform, stating that Hainan’s duty-free policy can drive diversified pharmacy services...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0209","BK1161","LU1969619763.USD","159938","BK1515","LU2328871848.SGD","BK1574","BK0097","BK0077","002727","09939"],"gpt_icon":0},{"id":"2614045434","title":"Zai Lab posts Q4 product revenue of USD 127.1 million, up 17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614045434","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614045434?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:02","pubTimestamp":1772107356,"startTime":"0","endTime":"0","summary":"Zai Lab posts Q4 product revenue of USD 127.1 million, up 17%               Zai Lab reported Q4 2025 total revenues of USD 127.6 million, up 17.0% y-o-y, and FY 2025 total revenues of USD 460.2 millio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL3N8cVm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1588","BK1161","LU2488822045.USD","09688"],"gpt_icon":0},{"id":"2614304615","title":"Zai Lab Ltd - Total Revenues $127.6 Mln in Q4 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2614304615","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614304615?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:00","pubTimestamp":1772107203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUACCVBR2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1588","BK1574","09688","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"2614046486","title":"Zai Lab Ltd: Q4 Net Loss per Share $0.05","url":"https://stock-news.laohu8.com/highlight/detail?id=2614046486","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614046486?lang=en_us&edition=fundamental","pubTime":"2026-02-26 20:00","pubTimestamp":1772107203,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nTUACCVBR2:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09688","BK1574","BK1588","BK1161","LU2488822045.USD"],"gpt_icon":0},{"id":"1178136897","title":"BASECARE-B's Embryo Culture Medium Receives Chinese Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1178136897","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178136897?lang=en_us&edition=fundamental","pubTime":"2026-02-26 18:54","pubTimestamp":1772103260,"startTime":"0","endTime":"0","summary":"BASECARE-B (02170) has announced that its Geri embryo culture medium, a product within the Gems embryo culture series, received a Class III Medical Device Registration Certificate from China's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1222","09996","BK1100","09997","BK1574","BK1597","02170","159883"],"gpt_icon":0},{"id":"2614019615","title":"Jacobio Pharmaceuticals schedules board meeting to approve annual results","url":"https://stock-news.laohu8.com/highlight/detail?id=2614019615","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614019615?lang=en_us&edition=fundamental","pubTime":"2026-02-26 17:31","pubTimestamp":1772098309,"startTime":"0","endTime":"0","summary":"Jacobio Pharmaceuticals Group Co. Ltd. will hold a board meeting on Tuesday, March 10, 2026 to consider and approve the group’s annual results for the year ended December 31, 2025 and their publication, along with other business.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 26, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDL69lBc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"1142786194","title":"CANSINOBIO (06185) Issues 2025 Performance Report, Returns to Profitability","url":"https://stock-news.laohu8.com/highlight/detail?id=1142786194","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142786194?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:53","pubTimestamp":1772095996,"startTime":"0","endTime":"0","summary":"CANSINOBIO (06185) has released its 2025 performance report, showing an operating revenue of 1.068 billion yuan, a year-on-year increase of 26.18%. Net profit attributable to owners of the parent...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","06185","BK1161","BK1191"],"gpt_icon":0},{"id":"2614991820","title":"Zai Lab Reports Positive Phase 3 ADAPT OCULUS Results for VYVGART in Ocular Myasthenia Gravis","url":"https://stock-news.laohu8.com/highlight/detail?id=2614991820","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614991820?lang=en_us&edition=fundamental","pubTime":"2026-02-26 14:27","pubTimestamp":1772087241,"startTime":"0","endTime":"0","summary":"argenx reported positive topline results from the Phase 3 ADAPT OCULUS trial evaluating VYVGART  in adults with ocular myasthenia gravis. The randomized, double-blind, placebo-controlled study  met its primary endpoint, showing a statistically significant improvement versus placebo in MGII patient-reported ocular scores at Week 4 . The company said the trial data will be presented at an upcoming medical meeting and will support a planned supplemental Biologics License Application submission to the FDA to expand the product label into ocular myasthenia gravis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zai Lab Ltd. published the original content used to generate this news brief on February 26, 2026, and is solely responsible for the","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260226:nNDLCV6nT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1815333072.USD","LU0964807845.USD","LU0225283273.USD","LU2361044865.SGD","LU1066053197.SGD","LU1066051498.USD","LU0310799852.SGD","LU2242650005.HKD","LU0738911758.USD","LU0708995401.HKD","LU0353189763.USD","LU2326559502.SGD","LU2360032135.SGD","LU2023250843.SGD","LU0070217475.USD","LU0786609619.USD","LU0170899867.USD","LU0056508442.USD","LU0127658192.USD","LU0011850046.USD","IE0009356076.USD","LU1718418525.SGD","LU1868836757.USD","LU0265550359.USD","IE0034235303.USD","GB00B4LPDJ14.GBP","IE00B7KXQ091.USD","LU1145028129.USD","LU0784383803.USD","LU2236285917.USD","BK1574","IE00BFSS8Q28.SGD","LU2720916845.USD","LU2125154935.USD","LU2552382215.SGD","LU1074936037.SGD","LU1914381329.SGD","LU1674673428.USD","LU1366192091.USD","IE00BJTD4V19.USD","LU0795875169.SGD","IE00BQXX3F31.USD","LU1003077747.HKD","LU2543165471.USD","LU0648001328.SGD","LU1868837136.USD","IE00BJJMRX11.SGD","SG9999002224.SGD","LU2265009873.SGD","LU1852331112.SGD","LU0545039389.USD","LU2237957902.USD","LU2087621335.USD","LU1861558580.USD","IE00B4YYXB79.USD","LU0308772762.SGD","LU1868837300.USD","IE00B1XK9C88.USD","LU1242518857.USD","IE00BFSS7M15.SGD","LU0444971666.USD","LU2461242641.AUD","IE00BKDWB100.SGD","LU0553294199.USD","LU0348723411.USD","SG9999014906.USD","HK0000914660.USD","LU2381873111.SGD","LU1670710588.SGD","LU1699723380.USD","LU0079474960.USD","LU0476273544.USD","IE00B5949003.HKD","SG9999014880.SGD","LU2552382058.USD","LU0640476718.USD","LU2430703095.HKD","LU1489326972.SGD","LU0912757837.SGD","IE00BMPRXN33.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BMPRXR70.SGD","LU1670710661.SGD","LU0323591593.USD","LU2168564495.EUR","LU2360106780.USD","SGXZ31699556.SGD","LU2430703251.USD","LU0061475181.USD","LU0203202063.USD","LU0061474960.USD","LU0265550946.USD","LU0096364046.USD","SG9999014914.USD","LU2404859667.USD","LU0316494557.USD","LU1917777945.USD","LU0979878070.USD","LU0724617625.USD","SGXZ81514606.USD","LU0985489474.SGD","LU1201861249.SGD","LU0215105999.USD","IE00BJLML261.HKD","LU2746668461.USD","LU0061474705.USD","LU0889565833.HKD","LU2403377893.USD","LU1116320901.HKD","LU0006306889.USD","LU0320765489.SGD","LU1232071149.USD","BK4592","LU1064131342.USD","LU0154236417.USD","GB00BDT5M118.USD","LU2458330243.SGD","IE000W1ABFV2.USD","LU0106261372.USD","LU0354030511.USD","IE00BK4W5M84.HKD","LU1435385759.SGD","LU1732800096.USD","LU2065170008.USD","LU2592432038.USD","LU0690374615.EUR","BK4543","LU1778281490.HKD","LU1823568750.SGD","LU1974910355.USD","LU0689472784.USD","BK4077","LU2054465674.USD","LU1839511570.USD","SGXZ51526630.SGD","IE0003U64NQ7.SGD","LU2473716301.USD","IE00BQXX3D17.EUR","LU1670627923.USD","IE00B775H168.HKD","LU2756315318.SGD","LU0795875086.SGD","LU0109392836.USD","BK1161","LU0203201768.USD","LU1868836591.USD","IE00B19Z8X17.USD","LU0878866978.SGD","LU0068578508.USD","IE0034235188.USD","GB00B4QBRK32.GBP","IE00B1BXHZ80.USD","LU1868836914.USD","LU1988902786.USD","IE00B19Z8W00.USD","LU1366333091.USD","LU0642271901.SGD","LU2505996681.GBP","IE00B19Z9505.USD","LU0949170426.SGD","LU1670628061.USD","IE0009G5SDU7.USD","LU0211331839.USD","LU2488822045.USD","LU2322448791.USD","LU1564329461.SGD","LU1551013342.USD","LU0949170772.SGD","LU1301847155.USD","LU1551013425.SGD","LU2347655156.SGD","LU2063271972.USD","LU2456880835.USD","IE0004445015.USD","LU1670711123.USD","LU1069344957.HKD","LU2272731865.HKD","LU0210528500.USD","LU1720051017.SGD","LU1267930730.SGD","BK4507","LU0788109477.HKD","LU1815336760.USD","LU2250418816.HKD","IE00BK4W5L77.USD","SG9999018865.SGD","LU0096362180.USD","IE00B4JS1V06.HKD","LU0070302665.USD","LU0203347892.USD","LU2462157665.USD","SG9999014898.SGD","LU2764263203.CNY","LU2860962120.EUR","LU0353189680.USD","LU0820561909.HKD","LU1084165304.USD","LU2505996509.AUD","LU0417517546.SGD","IE000KEQY171.SGD","LU1674673691.USD","IE00BJJMRY28.SGD","SG9999004303.SGD","LU0787776722.HKD","SGXZ23171101.USD","IE00BMPRXQ63.HKD","LU2065171311.SGD","LU0820562030.AUD","LU0672654240.SGD","LU1235294995.USD","HK0000914686.HKD","SG9999015952.SGD","LU1564329628.SGD","LU0276348264.USD","IE0001KFT4U8.USD","LU1127390331.HKD","LU0690374961.EUR","LU1429558221.USD","LU0053666078.USD","IE00BQXX3C00.GBP","LU1629891620.HKD","LU0823434740.USD","LU2125154778.USD","LU1861559042.SGD","LU2133065610.SGD","LU0345769128.USD","LU1153585028.USD","LU0882574139.USD","LU0980610538.SGD","LU2322448957.HKD","LU0784385840.USD","LU2552382132.HKD","IE000YTNTUN2.SGD","LU0109391861.USD","LU0210536198.USD","LU0433182093.SGD","BK4585","LU0943347566.SGD","LU0719512351.SGD","LU0082616367.USD","LU1548497426.USD","LU0444973449.USD","LU0466842654.USD","LU0211327993.USD","LU0072462426.USD","LU2023250330.USD","LU0820561818.USD","LU0784385170.HKD","LU1697837992.HKD","IE000ITXATA3.USD","LU1280957306.USD","LU2247934214.USD","LU2361044949.HKD","LU1035775433.USD","LU1720051108.HKD","LU2168564149.EUR","LU1267930490.SGD","LU0203345920.USD","LU0130102774.USD","LU2065171402.SGD","LU0208291251.USD","LU1791710400.SGD","LU2361045086.USD","IE00BN29S564.USD","LU1261432733.SGD","SG9999015978.USD","LU2357305700.SGD","LU0097036916.USD","LU2237957811.SGD","LU0198837287.USD","LU2087625088.SGD","LU0256863902.USD","SG9999002232.USD","LU2487616109.SGD","SG9999015986.USD","IE00B3SWFQ91.USD","BK1588","LU0957808578.USD","IE00BWXC8680.SGD","LU0345769631.USD","LU0077335932.USD","LU2097829019.USD","LU0354030438.USD","LU2430703178.SGD","LU0957791311.USD","LU1242518931.SGD","SG9999001077.SGD","LU0823421333.USD","IE00B7SZLL34.SGD","LU1670711040.USD","LU2458330169.SGD","LU0985320562.USD","LU2404859741.USD","LU1992135472.HKD","LU2168564222.USD","LU2347655073.USD","LU2420271590.USD","LU0320765059.SGD","LU0157215616.USD","LU1564329115.USD","LU2417539215.USD","LU0234570918.USD","LU2317271919.USD","LU0823434583.USD","LU0683600562.USD","SG9999018857.SGD","09688","LU2896262040.SGD","LU2463028550.USD","IE00B19Z3B42.SGD","BK4588","LU1804176565.USD","LU1119994496.HKD","BK4524","LU0823421416.USD","LU0211328371.USD","LU2065169927.USD","LU2764262908.HKD","LU0528227936.USD","LU1496350502.SGD","LU1316542783.SGD","LU0080751232.USD","LU1732799900.SGD","LU1791710582.SGD","IE00B19Z3581.USD","LU1992135399.USD","LU0149725797.USD","LU2764263039.SGD","IE0004445239.USD","SGXZ99366536.SGD","BK4587","LU2106854487.HKD","ZLAB","LU1116320737.USD","LU2213496289.HKD","LU0267386448.USD","LU2168564065.EUR","LU1803068979.SGD","LU1642822529.SGD","LU2264538146.SGD","LU2272731782.SGD","LU2602419157.SGD","LU2756315664.SGD","LU1571399168.USD","LU2272731600.USD","LU0661504455.SGD","LU0256863811.USD","IE0002270589.USD","LU0784384876.USD","SG9999015945.SGD","LU1046421795.USD","LU0210533765.USD","LU2746668974.SGD","SG9999017495.SGD","IE0005OL40V9.USD","LU1564329032.USD","LU2168563687.JPY","IE00BJTD4N35.SGD","LU0726765562.USD","LU0234572021.USD"],"gpt_icon":0},{"id":"1143669789","title":"Hong Kong Stock Connect Biotech Sector Declines, ETF 520880 Drops Over 1% Amid Wide Premium","url":"https://stock-news.laohu8.com/highlight/detail?id=1143669789","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143669789?lang=en_us&edition=fundamental","pubTime":"2026-02-26 10:50","pubTimestamp":1772074259,"startTime":"0","endTime":"0","summary":"During the morning session on February 26, the innovative drug sector in Hong Kong stocks experienced a volatile downturn. The Hong Kong Stock Connect Innovative Drug ETF (520880), which focuses...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","VXUS","BK1574","BK1161","520880","BK4588","BK4585","VT","159992"],"gpt_icon":0},{"id":"2614064310","title":"Immunotech Biopharm Invests 50 Million Yuan in Structured Deposit Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2614064310","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614064310?lang=en_us&edition=fundamental","pubTime":"2026-02-26 10:15","pubTimestamp":1772072121,"startTime":"0","endTime":"0","summary":"Immunotech Biopharm  invested 50 million yuan in a structured deposit product from SPD Bank, according to a Hong Kong bourse filing Wednesday.The 29-day product has an expected annualized rate of return of 0.70% or 2% to 2.2%, depending on the prevailing EUR/USD spot exchange rate on March 26, around the time the product expires.The firm said the investment will help utilize idle cash.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","BK1574","06978"],"gpt_icon":0},{"id":"1114907205","title":"Zhongtai Securities: Maintaining Focus on Healthcare's Structural Opportunities and Medical AI+","url":"https://stock-news.laohu8.com/highlight/detail?id=1114907205","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114907205?lang=en_us&edition=fundamental","pubTime":"2026-02-26 07:28","pubTimestamp":1772062107,"startTime":"0","endTime":"0","summary":"Zhongtai Securities released a research report stating that the healthcare sector, which combines both technological and consumer characteristics, is expected to continue exhibiting structural trends...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","150261","BK1515","BK1161","159938","09939","BK0276","600918"],"gpt_icon":0},{"id":"2614365990","title":"BRIEF-Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2614365990","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614365990?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:06","pubTimestamp":1772031975,"startTime":"0","endTime":"0","summary":"BRIEF-Immunotech Biopharm Subscribes To Structured Deposit Product With Investment Value Of RMB50 MLNFeb 25  - Immunotech Biopharm Ltd 6978.HK:SUBSCRIBED TO STRUCTURED DEPOSIT PRODUCT WITH INVESTMENT VALUE OF RMB50 MILLIONFurther company coverage: 6978.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06978","BK1574"],"gpt_icon":0},{"id":"1107726448","title":"IMMUNOTECH-B Allocates 50 Million Yuan to Structured Deposit from Shanghai Pudong Development Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=1107726448","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107726448?lang=en_us&edition=fundamental","pubTime":"2026-02-25 23:04","pubTimestamp":1772031856,"startTime":"0","endTime":"0","summary":"IMMUNOTECH-B (06978) has announced the acquisition of a structured deposit product from Shanghai Pudong Development Bank Co.,Ltd. on February 25, 2026, with a total investment value of RMB 50 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","06978","LU0469268626.HKD","LU1808992512.USD","LU1934453819.USD","BK0086","BK0201","BK0188","BK0015","BK1161","BK0187","BK0012","SGXZ49509284.SGD","600000","LU1979443071.USD","BK0183","SGXZ81163826.USD","BK1574","BK0278"],"gpt_icon":0},{"id":"2614003505","title":"Immunotech Biopharm -  Subscribed to Structured Deposit Product With Investment Value of RMB50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2614003505","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614003505?lang=en_us&edition=fundamental","pubTime":"2026-02-25 22:59","pubTimestamp":1772031583,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nFWN3ZL1NE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06978","BK1161","BK1574"],"gpt_icon":0},{"id":"1118411444","title":"Revised title","url":"https://stock-news.laohu8.com/highlight/detail?id=1118411444","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118411444?lang=en_us&edition=fundamental","pubTime":"2026-02-25 20:14","pubTimestamp":1772021665,"startTime":"0","endTime":"0","summary":"Hanfang Pharmaceutical Submits Listing Application to Hong Kong Stock Exchange","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1574","HEXmain","BK1191"],"gpt_icon":0},{"id":"1173309936","title":"AH Share Premium Rankings as of February 25","url":"https://stock-news.laohu8.com/highlight/detail?id=1173309936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173309936?lang=en_us&edition=fundamental","pubTime":"2026-02-25 16:21","pubTimestamp":1772007697,"startTime":"0","endTime":"0","summary":"As of the market close on February 25, NE ELECTRIC (00042), Zhejiang Shibao Company Limited (01057), and SINOPEC SSC (01033) recorded the highest AH share premium rates, at 550.60%, 337.32%, and...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516738.SGD","LU0266512127.USD","LU0588545730.USD","LU1048596156.SGD","LU1051768304.USD","LU0072913022.USD","LU0871576103.HKD","LU0235996351.USD","BK1148","LU0329678170.USD","LU2097828474.EUR","LU0531971595.HKD","LU0449515922.USD","SG9999001903.USD","LU0880133367.SGD","LU0594300179.USD","BK1124","LU0043850808.USD","LU0593848301.USD","LU1961090484.USD","LU1251922891.USD","BK1214","BK1506","HK0000306685.HKD","LU1642822792.SGD","LU0828237940.HKD","LU2543165471.USD","LU0831103253.SGD","BK1184","LU0231483743.USD","LU0197773160.USD","LU0611395673.USD","LU0328353924.USD","LU1770034418.SGD","LU0831093199.SGD","LU0791591158.USD","BK1174","LU0865486749.SGD","LU0315178854.USD","BK1560","LU0287142896.SGD","LU0516423174.USD","01033","LU0862451837.USD","LU2424517915.HKD","LU0096374516.USD","LU0650527681.SGD","LU2476274308.USD","IE00BF5LJ272.USD","LU0588545904.SGD","LU0856984785.SGD","BK1523","LU2226246903.HKD","LU0572944931.SGD","CIHKY","IE00BMCWC346.EUR","LU0052750758.USD","IE00B29SXG58.USD","LU0173614495.USD","LU0315179316.USD","LU1675838814.USD","BK1562","LU0862451753.SGD","LU0898667661.SGD","LU0348816934.USD","LU1807302812.USD","IE00BZ08YR35.GBP","LU0211977185.USD","LU2778985437.USD","BK1501","LU1794554557.SGD","LU0359201885.HKD","LU0359202008.SGD","LU1211504680.USD","LU0039217434.USD","LU0345780521.USD","LU0164872284.USD","LU0630378692.HKD","LU0651946864.USD","82318","LU0326950275.SGD","LU0165289439.USD","LU1960683339.HKD","LU0244354667.USD","BK1229","LU1769817179.HKD","LU0417516902.SGD","LU0329678337.USD","BK1546","LU0307460666.USD","600036","LU1282651121.HKD","LU0762540952.USD","LU0648948544.HKD","LU0106252389.USD","03750","LU0469268626.HKD","LU2399975544.HKD","LU1188198961.HKD","BK1171","LU0886674414.USD","LU1282649141.HKD","LU1224444064.USD","LU2348774022.SGD","00042","LU1226287529.USD","LU0149534421.HKD","LU1808992512.USD","SG9999006597.SGD","BK1583","LU2039709279.SGD","LU0196878994.USD","IE00BZ08YT58.USD","LU0345780281.USD","LU0488056044.USD","03143","LU2045819591.USD","HK0000352382.USD","LU1504937902.USD","LU0516422440.USD","LU1981816686.USD","LU0314109678.HKD","BK1144","LU1282651048.USD","PNGAY","LU1328277881.USD","IE00B543WZ88.USD","LU0266512473.USD","LU0918141705.HKD","LU0417516571.SGD","LU0634319403.HKD","LU0359201612.USD","BK1576","LU1880383366.USD","HK0000306701.USD","BK1240","LU3063872942.SGD","LU0051755006.USD","LU0320764599.SGD","LU0431992006.USD","BK1116","LU1282648689.USD","BK1535","LU0117844026.USD","03145","IE0008368742.USD","BK1514","LU0293314216.USD","IE00B3M56506.USD","BK1521","IE0034224299.USD","LU0819123356.HKD","BK1507","LU1105468828.SGD","LU0327786744.USD","LU0011963245.USD","LU1044876610.USD","300750","LU0348783233.USD","LU1282649810.SGD","LU0370786039.SGD","LU0348825331.USD","LU0561508036.HKD","LU0348783662.USD","IE00B0169L03.USD","BK1258","IE00BPRC5H50.USD","LU1044874839.SGD","LU0384037296.USD","LU0456846285.SGD","LU2293587155.HKD","IE0008369823.USD","LU0819121731.USD","LU1655091459.SGD","BK1237","IE00B031J352.USD","BK1522","LU0588546209.SGD","LU0149721374.USD","LU0164939612.USD","LU1235295612.USD","LU1303224171.USD","LU0456827905.SGD","LU1366334578.USD","LU2348773727.SGD","LU0082770016.USD","LU0061477393.USD","BK1550","BK1515","LU0605514214.HKD","IE00BYV24P56.USD","LU0348784397.USD","LU0072462343.USD","SG9999004220.SGD","LU1008478684.HKD","LU1769817096.USD","LU0348788117.USD","BK1564","LU0823426480.USD","LU0348735423.USD","HK0000352291.HKD","SG9999002828.SGD","LU1224709979.USD","LU0620787316.HKD","LU0501845795.SGD","IE00BGHQDM52.EUR","603986","LU0348814723.USD","03968","LU1242518931.SGD","LU2476274720.SGD","LU1813983027.USD","LU0594300419.USD","LU0737861772.HKD","LU1023057109.AUD","BK1147","LU0607220059.USD","LU1115378108.SGD","BK1544","BK1110","LU0067412154.USD","LU1152091754.HKD","BK1592","SG9999002562.SGD","LU0463099449.HKD","LU0054450605.USD","LU0797268264.HKD","IE0031814852.USD","LU0516422366.SGD","LU1282649067.USD","159982","BK1554","HPAD.SI","LU0254981946.USD","LU1044875133.USD","LU1880383440.USD","LU2097828631.EUR","LU0540923850.HKD","LU2097828805.USD","LU0197773673.USD","LU0228659784.USD","LU0049853897.USD","LU0791590937.USD","03986","LU2242644610.SGD","LU2125910500.SGD","LU2152927971.USD","LU0441854154.USD","LU0164865239.USD","BK1149","BK1141","LU0084288322.USD","LU0918141887.USD","IE00B5MMRT66.SGD","LU0516422952.EUR","BK1161","002703","LU0210527791.USD","SG9999002463.SGD","LU1481107354.HKD","BK1505","LU0229945570.USD","LU0348805143.USD","BK1105","LU0348827113.USD","601318","LU0675040207.SGD","BK1543","LU0878004406.USD","LU0502904849.HKD","LU0516423091.SGD","600871","HK0000320223.HKD","HK0000320264.USD","LU0630378429.USD","LU0762542818.HKD","LU0456854461.SGD","LU0455707207.USD","IE00BVYPNP33.GBP","LU0117841782.USD","LU1146622755.USD","LU1051769294.HKD","LU0164880469.USD","LU0737861699.HKD","LU1993786604.SGD","LU0640798160.USD","LU0882747503.HKD","LU0543330566.HKD","LU2153591404.USD","IE00BZ08YS42.EUR","LU0181495838.USD","LU0821914370.USD","SG9999014674.SGD","LU0228367735.SGD","LU1048588211.SGD","LU0082770016.SGD","LU1242518857.USD","IE00B031HY20.USD","BK1551","LU0784639295.USD","LU0878005551.USD","SG9999000459.SGD","LU0868486357.SGD","LU1720050803.USD","LU1688375341.USD","LU0106959298.USD","LU2097828714.EUR","BK1223","LU1719994722.HKD","LU0651947912.USD","BK1231","LU0589944569.HKD","LU1515016050.SGD","LU0762541174.USD","LU0823426308.USD","LU1366334651.USD","LU0163747925.USD","399300","LU0890818403.SGD","IE0003895053.USD","BK1198","LU0140636845.USD","LU0979878070.USD","BK1191","LU0708995583.HKD","BK1183","PAImain","BK1594","01057","IE00BVYPNQ40.USD","LU0828237510.HKD","LU0048580855.USD","LU1820825898.SGD","LU1831875114.USD","LU0049112450.USD","BK1202","BK1574","BK1163","LU1046422090.SGD","LU1152091168.USD","BK1610","LU2097828557.USD","LU0588545490.SGD","LU2153592121.USD"],"gpt_icon":1},{"id":"1196731985","title":"Antengene-B Shares Surge Over 6% Following Clinical Collaboration Agreement with Junshi Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1196731985","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196731985?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:20","pubTimestamp":1772000437,"startTime":"0","endTime":"0","summary":"Antengene-B (06996) rose more than 6%, with the stock up 6.4% to HK$3.66 at the time of writing, recording a turnover of HK$13.326 million. The company announced this morning that it has entered into...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","06996","BK4588","688180","VT","BK4585","VXUS","BK1161","01877","BK1515","BK1574","BK1583"],"gpt_icon":0},{"id":"1109278324","title":"CStone Pharmaceuticals-B Sees Further Gains Exceeding 6%, Surpassing 25% Monthly Increase","url":"https://stock-news.laohu8.com/highlight/detail?id=1109278324","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109278324?lang=en_us&edition=fundamental","pubTime":"2026-02-25 14:10","pubTimestamp":1771999823,"startTime":"0","endTime":"0","summary":"CStone Pharmaceuticals-B (02616) rose more than 6% again, bringing its cumulative increase for the month to over 25%. As of the time of writing, the stock was up 5.03%, trading at HK$6.68 with a...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VT","BK1574","02616","BK4585","BK1161","BK4588","VXUS","BK4134","III"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":115,"code":"91000000","status":"200"}]}}